Shanghai Zhaohui Pharmaceutical Co., Ltd.

Shanghai Zhaohui Pharmaceutical Co., Ltd. was founded in 1958. Since its restructuring in 1999, it joined the Fosun Group, and in 2002, it relocated to a new production base in Baoshan District. In 2013 and 2017, it constructed the second-phase preparation building, third-phase raw material building, and automated high-bay warehouse. To date, Zhaohui Pharmaceutical has invested over 310 million yuan in total. The company currently covers an area of 100 mu, with a green coverage rate exceeding 36.8%, and a registered capital of 100 million yuan.
The company currently operates multiple GMP-compliant production lines, including small-volume injections, tablets (including anti-tumor drugs), hard capsules (including anti-tumor drugs), ointments (including hormone-containing), creams (including hormone-containing), and active pharmaceutical ingredients (APIs).
With over 350 employees, the company relies on several technology centers and industrialization bases, and collaborates with various universities to jointly build talent training bases, forming a highly competitive R&D team. The company emphasizes talent development, establishing a comprehensive management system for talent standards, evaluation, and training, providing employees with broad career development opportunities, and enabling employees to grow and share success with the company.